bf/NYSE:EBS_icon.jpeg

COM:EMERGENTBIOSOLUTIONS

Emergent BioSolutions

  • Stock

Last Close

8.88

21/11 21:00

Market Cap

487.34M

Beta: -

Volume Today

1.28M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
312.75M
-
450.14M
43.93%
522.79M
16.14%
488.78M
6.50%
560.87M
14.75%
782.40M
39.50%
1.11B
41.36%
1.56B
40.63%
1.79B
15.26%
1.12B
37.47%
1.05B
6.39%
cost of revenue
62.13M
-
118.41M
90.60%
124.30M
4.97%
131.28M
5.62%
195.71M
49.07%
322.30M
64.68%
433.50M
34.50%
524M
20.88%
757.50M
44.56%
693.70M
8.42%
756.80M
9.10%
gross profit
250.62M
-
331.73M
32.36%
398.49M
20.13%
357.50M
10.29%
365.17M
2.14%
460.10M
26.00%
672.50M
46.16%
1.03B
53.37%
1.04B
0.37%
427.20M
58.73%
292.50M
31.53%
selling and marketing expenses
general and administrative expenses
87.88M
-
122.84M
39.78%
148.46M
20.85%
143.69M
3.21%
143.50M
0.13%
202.50M
41.12%
selling general and administrative expenses
87.88M
-
122.84M
39.78%
148.46M
20.85%
143.69M
3.21%
143.50M
0.13%
202.50M
41.12%
273.50M
35.06%
303.30M
10.90%
348.40M
14.87%
340.30M
2.32%
356.70M
4.82%
research and development expenses
119.93M
-
150.83M
25.76%
154.00M
2.10%
108.29M
29.68%
97.38M
10.07%
142.80M
46.64%
226.20M
58.40%
234.50M
3.67%
234M
0.21%
193M
17.52%
107.80M
44.15%
other expenses
426K
-
2.93M
586.85%
-319K
110.90%
263K
182.45%
-815K
409.89%
1.60M
296.32%
58.70M
3,568.75%
59.80M
1.87%
58.50M
2.17%
59.90M
2.39%
8.90M
85.14%
cost and expenses
269.94M
-
392.08M
45.25%
426.75M
8.84%
383.26M
10.19%
436.59M
13.91%
692.60M
58.64%
991.90M
43.21%
1.12B
13.08%
1.40B
24.68%
1.29B
7.97%
1.22B
5.10%
operating expenses
207.82M
-
273.67M
31.69%
302.45M
10.52%
251.98M
16.69%
240.88M
4.40%
370.30M
53.73%
558.40M
50.80%
597.60M
7.02%
640.90M
7.25%
593.20M
7.44%
464.50M
21.70%
interest expense
8.24M
-
6.52M
20.84%
7.62M
16.77%
6.59M
13.48%
9.90M
50.23%
38.40M
287.88%
31.30M
18.49%
34.50M
10.22%
37.30M
8.12%
96.80M
159.52%
ebitda
62.33M
-
93.75M
50.43%
131.63M
40.39%
106.84M
18.83%
125.22M
17.21%
116.40M
7.05%
226.50M
94.59%
553M
144.15%
514.40M
6.98%
-34.40M
106.69%
-42.90M
24.71%
operating income
42.80M
-
58.06M
35.64%
96.04M
65.42%
105.52M
9.87%
124.28M
17.78%
89.80M
27.75%
114.10M
27.06%
433.80M
280.19%
352.60M
18.72%
-166M
147.08%
-172M
3.61%
depreciation and amortization
18.96M
-
32.45M
71.18%
35.34M
8.88%
38.23M
8.19%
42.57M
11.36%
25M
41.28%
112.40M
349.60%
119.20M
6.05%
161.80M
35.74%
131.60M
18.67%
129.10M
1.90%
total other income expenses net
426K
-
2.93M
586.85%
-319K
110.90%
263K
182.45%
-815K
409.89%
1.60M
296.32%
-36.70M
2,393.75%
-26.60M
27.52%
-38.20M
43.61%
-55.70M
45.81%
-559.20M
903.95%
income before tax
43.37M
-
53.06M
22.36%
89.77M
69.18%
99.22M
10.53%
118.63M
19.56%
81.50M
31.30%
77.40M
5.03%
407.20M
426.10%
314.40M
22.79%
-221.70M
170.52%
-731.20M
229.82%
income tax expense
13.11M
-
16.32M
24.51%
26.90M
64.81%
36.70M
36.43%
36.04M
1.79%
18.80M
47.83%
22.90M
21.81%
102.10M
345.85%
83.50M
18.22%
2.10M
97.49%
29.30M
1,295.24%
net income
31.14M
-
36.74M
18.01%
62.87M
71.12%
51.78M
17.65%
82.59M
59.52%
62.70M
24.09%
54.50M
13.08%
305.10M
459.82%
230.90M
24.32%
-223.80M
196.93%
-760.50M
239.81%
weighted average shs out
36.20M
-
37.34M
3.16%
38.60M
3.35%
40.18M
4.12%
41.82M
4.06%
50.10M
19.81%
51.50M
2.79%
52.70M
2.33%
53.50M
1.52%
50.10M
6.36%
51.20M
2.20%
weighted average shs out dil
36.75M
-
45.80M
24.64%
47.26M
3.17%
49.34M
4.40%
50.33M
2.01%
51.40M
2.13%
52.40M
1.95%
53.80M
2.67%
54.10M
0.56%
50.10M
7.39%
51.20M
2.20%
eps
0.86
-
0.98
13.95%
1.63
66.33%
1.29
20.86%
1.98
53.49%
1.25
36.87%
1.06
15.20%
5.79
446.23%
4.32
25.39%
-4.47
203.47%
-14.85
232.21%
epsdiluted
0.85
-
0.88
3.53%
1.41
60.23%
1.13
19.86%
1.71
51.33%
1.22
28.65%
1.04
14.75%
5.67
445.19%
4.27
24.69%
-4.47
204.68%
-14.85
232.21%

All numbers in (except ratios and percentages)